Cancer diagnoses across England have reached unprecedented levels, with more than 1,000 people receiving a diagnosis every day, according to figures released by NHS England. However, the health service continues to fall short of its own targets for both diagnosis and treatment timescales, raising concerns among medical professionals about patient outcomes.
According to The Guardian, NHS England identified 373,574 new cancer cases in 2024, representing an increase of 11,833 diagnoses compared with 2023. On average, the health service diagnosed 1,021 people with cancer each day throughout 2024, up from 972 daily diagnoses in 2023. When including basal cell and cutaneous squamous cell skin cancers, the total reached 616,404 cases for the year.
Prostate, breast, lung and bowel cancers together accounted for approximately half of all newly diagnosed cases. Prostate cancer was the most frequently diagnosed malignancy in 2024, with 61,115 cases recorded—a rise of 4.1% from the previous year.
The data did reveal some positive developments in early detection. The proportion of newly diagnosed cancers identified at stage 1 or 2 improved to 56.7% in 2024 from 55.8% in 2023. NHS England has stated an ambition for 75% of cancers to be diagnosed at these earlier stages, though early-stage diagnosis rates had remained relatively flat at around 55% from 2013 until the pandemic disrupted services.
Prof Peter Johnson, the national clinical director for cancer at NHS England, characterised the figures as evidence that the health service was progressing in the right direction.
NHS teams across the country are taking tests and checks closer to the people who need them, and with new treatments being developed all the time, we will continue to do all we can to get people seen and treated for cancer as early as possible.
Why are waiting time targets being missed?
Despite the increase in diagnoses, the NHS is failing to meet established performance benchmarks. In August 2026, only 78.6% of patients in England who were urgently referred for suspected cancer received a diagnosis or had cancer ruled out within the 28-day target window. The shortfall is even more pronounced for treatment initiation: just 71.9% of patients began cancer treatment within 62 days of an urgent referral or consultant upgrade, falling well short of the 85% target.
This pattern of missed targets reflects broader challenges within cancer services. Earlier reporting documented that England's cancer treatment performance had been worsening, with only 69.9% of patients starting treatment within the 62-day target, and experts warned that thousands would die unnecessarily without urgent action to address workforce shortages and diagnostic capacity.
What infrastructure improvements are underway?
The government has begun expanding diagnostic capacity to support earlier detection and faster treatment pathways. On 3 November 2026, the government announced that NHS England had added 125 CT and MRI scanners between March 2024 and March 2026, enabling one million additional scans to be performed. Every month in 2026 to date has set a record for diagnostic activity, according to government figures.
What do medical experts say about the figures?
Dr Ian Walker, the executive director of policy at Cancer Research UK, acknowledged the increased diagnostic activity but warned that progress remained insufficient. He stated that while NHS staff are diagnosing more people with cancer every day, too many are still being identified at advanced stages when treatment options are more limited and outcomes typically poorer.
Walker emphasised that the health service required additional support to reduce late-stage diagnoses and ensure patients receive timely treatment.
The UK government pledged to improve early diagnosis, cancer waiting times and access to treatment in its national cancer plan for England. It now needs to keep its foot on the pedal to ensure cancer patients aren't let down. The situation won't change without focused effort from the government, clear accountability, and a guarantee that the NHS will get the specialist staff and equipment it needs.
Dr Hilary Williams, the clinical vice-president at the Royal College of Physicians and a consultant in medical oncology, characterised the daily diagnosis figure as a stark indicator of mounting pressure on cancer services.
More than 1,000 cancer diagnoses every day is a stark reminder of the growing demand on NHS cancer services.
Williams identified an ageing population as a significant driver of increased diagnoses but highlighted obesity as a major and frequently underrecognised risk factor for cancer development. She advocated for continued improvements in early detection methods, including expansion of targeted lung cancer screening programmes.
As more people are diagnosed and live longer with cancer, we must ensure they can access the specialist care and support they need.
How do health inequalities affect cancer outcomes?
Steven McIntosh, the chief partnerships officer at Macmillan Cancer Support, cautioned that the aggregate figures obscured persistent disparities in cancer incidence and survival across different populations.
We know that who you are and where you live can still have a significant impact on how likely you are to get cancer, as well as how quickly you are diagnosed and your chances of survival.
Rachael Franklin, the deputy chief executive of Breast Cancer Now, noted that breast cancer remains the leading cause of death among working-age women in the UK, with one in seven women receiving a diagnosis during their lifetime.
That's why it's so important that people of all ages are breast aware and get anything new or unusual checked by a GP as soon as possible. We also urge all eligible women to attend their screening appointment when invited.
Concerns about diagnostic delays have been documented across the UK. Welsh GPs have reported that 10-minute appointment slots are making it harder to conduct thorough gynaecological cancer checks and early detection, with research showing half of surveyed doctors view limited consultation time as a major barrier. Additionally, extended waits for scans and results in Northern Ireland have been characterised as dangerously long, as a shortage of radiologists has forced diagnostic imaging to be sent to Australia.
What happens next?
NHS England's September 2026 cancer waiting-time statistics are provisionally scheduled for release on 12 November 2026 at 9:30am, which will provide updated performance data on diagnosis and treatment timescales. These figures will indicate whether the infrastructure investments and policy initiatives have begun to narrow the gap between current performance and established targets.
